AbbVie Inc. has declared another quarterly dividend of $1.73 per share, payable November 16, 2026, to shareholders of record as of October 15, holding the payout steady throughout 2026 after raising it from $1.64 earlier in the year. The $1.73 quarterly payment works out to $6.92 per share annually and a yield of roughly 2.7%, a moderate level that AbbVie has not raised again this year. The company's dividend growth record is the larger story: the quarterly payout has climbed from $1.41 in 2022 to $1.48 in 2023, $1.55 in 2024, $1.64 in 2025 and $1.73 in 2026, a roughly 23% increase over that span, and AbbVie has raised its quarterly dividend by more than 330% since it was established in 2013, with the latest increase at 5.5%. In its latest SEC filing, AbbVie reported $7.27 billion in operating cash flow for the first six months of 2026, up from $6.79 billion a year earlier, while paying $6.2 billion in cash dividends during the same period, and it spent about $1.1 billion on acquisitions and investments and another $1.1 billion on share repurchases in that half. AbbVie said future dividends remain subject to board approval and cited its financial condition, capital requirements and debt obligations as factors.
AbbVie IncAbbVie declared a steady $1.73 quarterly dividend and highlighted its long dividend growth record and strong operating cash flow.
